Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzole

Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and niluzole

US Patent 6962976 · Granted Nov 8, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pain relief compounds2019
Therapy for promoting cell growth2019
Protein chips, preparation and use thereof2019
Use of riluzole for treating or preventing the adverse effects of antineoplastic2016
Use of K2P potassium channel activators as antalgics2016
Therapy for promoting cell growth2016
Peptides which have analgesic effects and which inhibit ASIC channels2015
Identification of novel antagonist toxins of T-type calcium channel for analgesi2014
Method of treating pain or itching with APETx2 peptide toxin2013
Method of treatment of retinal ischemia with diazoxide2011
Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatt2008
Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatt2008